BIOXALIS MEDICA

The companyโ€™s technology is based on the utilization of a hydrogel-based formulation to control sustained-release delivery properties of a drug or cosmeceutical product. It also engages in the research and development of products for use in the treatment of cancer. The company's efforts in oncology are focused on developing products for application as direct cancer treatment agents that have the dual objectives of extending life and improving the quality of life for cancer patients worldwide.

#More

BIOXALIS MEDICA

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical

Founded:
1997-01-01

Address:
Sainte-foy, Quebec, Canada

Country:
Canada

Status:
Active


More informations about "Bioxalis Medica"

Isabelle Caron โ€“ BMC

She has demonstrated her transformational leadership skills and leveraged her expertise within renowned organizations such as Labopharm, Bioxalis Medica, Laboratoires Confab, and more recently, Medicago. At the helm of the BMC, โ€ฆSee details»

Bioxalis Medica, Inc. - Drug pipelines, Patents, Clinical trials

Explore Bioxalis Medica, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Bioxalis Medica - Crunchbase

Bioxalis Medica Inc. develops drug delivery technologies for targeted liposomes for treating cancer.See details»

Bioxalis Medica inc. - LinkedIn

Bioxalis Medica inc. Biotechnology Research Quebec, QC 11 followers Follow Report this company About us Industry Biotechnology Research Company size 11-50 employees โ€ฆSee details»

Procyon Biopharma - Funding, Financials, Valuation & Investors

Jun 30, 2005 Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Bioxalis Medica . Jun 30, โ€ฆSee details»

Bioxalis Medica inc. - Products, Competitors, Financials, Employees ...

Bioxalis Medica inc. Use the CB Insights Platform to explore Bioxalis Medica inc.'s full profile. Bioxalis Medica inc. - Products, Competitors, Financials, Employees, Headquarters Locations โ€ฆSee details»

Bioxalis Medica Inc - Company Profile and News - Bloomberg โ€ฆ

Company profile page for Bioxalis Medica Inc including stock price, company news, executives, board members, and contact informationSee details»

Bioxalis Medica Inc Company Profile, Financial and ... - digitGaps

DigitGaps report on Bioxalis Medica Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and company โ€ฆSee details»

Maxime Ranger - Executive Chairman at Giiant Pharma - The Org

Maxime played different drug development roles in Montreal biotech companies, namely Ecopia Biosciences (which became Thallion Pharma, acquired by Bellus Health), Bioxalis Medica โ€ฆSee details»

101 Top BioPharma Startups & Companies (Canada)

An organization dedicated to the production of high quality vaccines and biopharmaceuticals Based out of Kingston, Ontario, Canada. ... Bioxalis Medica. Bioxalis Medica Inc. develops โ€ฆSee details»

Procyon Biopharma completes acquisition of Bioxalis Medica

Procyon Biopharma completes acquisition of Bioxalis Medica. July 4, 2005. No Comments. BioWorld Science Other news to note. Popular Stories. Today's news in brief. BioWorld. โ€ฆSee details»

Procyon Biopharma acquires Bioxalis Medica - Crunchbase

Procyon Biopharma acquires Bioxalis Medica on 2005-06-30 for $3500000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Bioxalis Medica acquired by Procyon โ€ฆSee details»

Bioxalis Medica inc. Stock Price, Funding, Valuation, Revenue ...

See Bioxalis Medica inc. funding rounds, investors, investments, exits and more. Evaluate their financials based on Bioxalis Medica inc.'s post-money valuation and revenue. Bioxalis Medica โ€ฆSee details»

PROCYON COMPLETES ACQUISITION OF BIOXALIS | FDAnews

Procyon Biopharma today announced the successful acquisition of Bioxalis Medica (Bioxalis), a Montreal-based biopharmaceutical company committed to the discovery and development of โ€ฆSee details»

BioCentury - Bioxalis Medica Inc., Procyon deal

Jul 4, 2005 Bioxalis Medica Inc., Procyon deal. WIR Staff. July 4, 2005 7:00 AM UTC. PBP acquired cancer company Bioxalis for 9 million PBP shares, valuing the deal at C$3.4 million โ€ฆSee details»

Cleantech: The colossal trillion-dollar business opportunity

Dec 11, 2017 Prior to heading Enerkem, Mr. Chornet was involved in the development and funding of industrial projects and start-up companies in the energy and specialty chemicals โ€ฆSee details»

Mohawk Medbuy and Plexxus Finalize Amalgamation

Mar 30, 2023 MMC provides value-driven contracting and procurement solutions for medical/surgical supplies, pharmaceutical products, local sourcing, capital equipment (FF&E) โ€ฆSee details»

Regulatory approval supports Laurentisโ€™s program to produce the โ€ฆ

Nov 10, 2021 Clarington, Ontario โ€“ A new program, led by Laurentis Energy Partners and BWXT Medical Ltd. (BWXT Medical), to produce the medical isotope Molybdenum-99 for the first time โ€ฆSee details»

Mirabel Medical Systems - Crunchbase

Mirabel Medical Systems, Inc. develops solutions for the non-invasive detection of breast cancer.See details»